Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $311,454 - $435,110
2,600 New
2,600 $386,000
Q3 2023

Nov 15, 2023

BUY
$138.78 - $176.51 $138,780 - $176,510
1,000 Added 55.56%
2,800 $445,000
Q2 2023

Aug 23, 2023

BUY
$138.42 - $180.31 $249,155 - $324,558
1,800 New
1,800 $254,000
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $612,522 - $980,247
-3,800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $940,842 - $1.16 Million
3,800 New
3,800 $992,000
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $1.3 Million - $2.17 Million
-6,700 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$165.87 - $220.95 $1.11 Million - $1.48 Million
6,700 New
6,700 $1.37 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $739,517 - $927,666
-4,100 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $148,080 - $206,570
-1,000 Reduced 19.61%
4,100 $775,000
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $4.23 Million - $5.46 Million
-34,500 Reduced 87.12%
5,100 $768,000
Q4 2019

Feb 12, 2020

SELL
$73.84 - $93.08 $1.42 Million - $1.79 Million
-19,200 Reduced 32.65%
39,600 $3.64 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $2.73 Million - $3.4 Million
35,600 Added 153.45%
58,800 $4.51 Million
Q2 2019

Aug 20, 2019

BUY
$54.2 - $85.95 $1.26 Million - $1.99 Million
23,200 New
23,200 $1.99 Million
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $556,263 - $665,532
-17,100 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$36.98 - $46.06 $632,358 - $787,626
17,100
17,100 $655,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.